Inspire Medical Systems, Inc. to Report First Quarter 2023 Financial Results on May 2, 2023

Rhea-AI Summary

Inspire Medical Systems (NYSE: INSP) is set to release its first-quarter 2023 financial results on May 2, 2023, after market close. A conference call will follow at 5:00 p.m. Eastern Time, where management will discuss results and recent business developments. Investors can access the call through the company’s Investor Relations webpage or via a direct link provided in the announcement. Inspire is known for its innovative Inspire therapy, the only FDA-approved neurostimulation treatment for moderate to severe obstructive sleep apnea, highlighting the company's focus on advancing medical technology in this specialized market.

Positive

• Inspire therapy is the first FDA-approved neurostimulation treatment for obstructive sleep apnea, indicating strong market positioning.

Negative

• None.

MINNEAPOLIS, April 04, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2023 after the close of trading on Tuesday, May 2. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q1 2023 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.

If you plan to ask a question, please use the following link: Inspire's Q1 2023 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call. 

Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443

FAQ

When will Inspire Medical Systems release its Q1 2023 financial results?

Inspire Medical Systems will release its Q1 2023 financial results on May 2, 2023.

What time is the Q1 2023 earnings call for Inspire Medical Systems?

The Q1 2023 earnings call for Inspire Medical Systems is scheduled for 5:00 p.m. Eastern Time on May 2, 2023.

Where can I access the Inspire Medical Systems Q1 2023 earnings call?

The earnings call can be accessed via Inspire's Investor Relations page or a provided direct link in the press release.

What is Inspire's focus in medical technology?

Inspire Medical Systems focuses on developing innovative, minimally invasive solutions for obstructive sleep apnea.